Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2009
06/18/2009WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound
06/18/2009WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
06/18/2009WO2009074590A1 N- (2 { [1-phenyl-1h-indaz0l-4-yl] amino} propyl) -sulfonamide derivatives as non-steroidal glucocorticoid receptor ligands for the treatment of inflammations
06/18/2009WO2009074339A1 Remedies for pemphigus containing anti fas ligand antobodies
06/18/2009WO2009074247A1 Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009074234A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009073916A1 Improved treatment and prophylaxis
06/18/2009WO2009073911A1 Treatment and prophylaxis
06/18/2009WO2009046864A3 Use of the human pancreatic polypeptide as a therapeutic agent
06/18/2009WO2009046847A3 Use of peptide ll-37 as a therapeutic agent
06/18/2009WO2009046846A3 Use of il-1 receptor peptide, alone or in combination with peptide ll-37, as a therapeutic agent
06/18/2009WO2009043476A3 Neuromedin s as a therapeutic agent
06/18/2009WO2009043448A3 Neuromedin u-25 and neuromedin s as therapeutic agents
06/18/2009WO2009043440A3 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
06/18/2009WO2009016081A3 Benzoind0l-2-one derivatives for use in therapy
06/18/2009WO2008129426A3 Medicaments and methods to treat autoimmune disease and cancer
06/18/2009WO2008065457A3 Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy
06/18/2009WO2008057855A9 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
06/18/2009WO2008056266A8 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives
06/18/2009US20090156803 Condensed furan compounds
06/18/2009US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
06/18/2009US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof
06/18/2009US20090156622 2,4-pyrimidinediamine compounds and their uses
06/18/2009US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
06/18/2009US20090156559 2-{[2-(Diethylamino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidate; chemical intermediates; free of by-products acrolein; release "cyclophosphate mustards" and do not require metabolic activation; anticarcinogenic agents; antitumor agents; autoimmune diseases
06/18/2009US20090156556 Aminopropanol derivatives
06/18/2009US20090156554 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases
06/18/2009US20090156546 Compositions and methods for modulating the immune system
06/18/2009US20090156540 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
06/18/2009US20090156480 Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein
06/18/2009US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
06/18/2009US20090155845 Molecules designated LDCAM
06/18/2009US20090155311 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
06/18/2009US20090155307 Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
06/18/2009US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
06/18/2009US20090155300 Basidiomycetes, basidiomycetes extract composition, health foods, and immunopotentiators
06/18/2009US20090155291 Method of increasing immunological effect
06/18/2009US20090155281 Methods of using antibodies that bind both bcma and taci
06/18/2009US20090155277 Use of immunesuppressant receptor
06/18/2009US20090155273 Remedies for inflammatory bowel diseases
06/18/2009US20090155270 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza
06/18/2009US20090155263 Compositions and methods for the treatment of immune related diseases
06/18/2009US20090155260 Use of thymosin alpha 1 for the treatment of immunological diseases
06/18/2009US20090155257 Immunoglobulin variants and uses thereof
06/18/2009US20090155243 Non-human model of autoimmune disease
06/18/2009US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
06/18/2009US20090155219 Methods for damaging cells using effector functions of anti-gfra1 antibodies
06/18/2009US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine
06/18/2009US20090155208 Methods and agents for modulating an immune response
06/18/2009US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa
06/18/2009US20090155203 Thrombopoietin mimetics
06/18/2009US20090155186 Compositions and methods for treating inflammatory conditions
06/18/2009US20090155174 RNA Interference Mediating Small RNA Molecules
06/18/2009CA2746551A1 Improved treatment and prophylaxis
06/18/2009CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
06/18/2009CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors
06/18/2009CA2709209A1 Method for producing dendritic cells
06/18/2009CA2708790A1 Remedies for pemphigus containing anti fas ligand antibodies
06/18/2009CA2708364A1 Carboxamide compounds and their use as chemokine receptor agonists
06/18/2009CA2708343A1 Method for increasing immunoreactivity
06/18/2009CA2706834A1 Thiophene derivatives as agonists of s1p1/edg1
06/18/2009CA2706813A1 Novel 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
06/18/2009CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
06/18/2009CA2706806A1 Novel 2-substituted tiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
06/18/2009CA2706679A1 Novel compounds 010
06/17/2009EP2071036A2 Methods for identifying RNA-binding compounds
06/17/2009EP2070948A1 Humanized Anti-CD4 antibody with immunosuppressive properties
06/17/2009EP2070947A1 Therapeutic and diagnostic anti-Hsp70 antibodies
06/17/2009EP2070939A1 Modulators of pharmacological agents
06/17/2009EP2070927A1 Fused heterocyclic derivative
06/17/2009EP2070925A1 New 2-substituted tiazol-4-carboxylic acid derivatives, their manufacture and use as medicine
06/17/2009EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine
06/17/2009EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors
06/17/2009EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels
06/17/2009EP2070916A1 2-Arylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine
06/17/2009EP2070550A1 Use of combinations comprising a corticosteroid and a pyrimidopyrimidine in the treatment of inflammatory diseases
06/17/2009EP2070542A2 Method of extended culture of antigen-specific cyotoxic T lymphocytes
06/17/2009EP2069404A1 Humanized anti-cd100 antibodies
06/17/2009EP2069336A1 Pyridin-4-yl derivatives as immunomodulating agents
06/17/2009EP2069335A1 Pyridin-3-yl derivatives as immunomodulating agents
06/17/2009EP2069333A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases
06/17/2009EP2069322A2 Thiophene derivatives as s1p1/edg1 receptor agonists
06/17/2009EP2069318A1 Phenyl derivatives and their use as immunomodulators
06/17/2009EP2069296A2 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
06/17/2009EP2068929A2 Method for detecting and treating skin disorders
06/17/2009EP2068921A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1
06/17/2009EP2068895A1 Selective chemokine modulation
06/17/2009EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use
06/17/2009EP1565431B1 Cannabinoid receptor ligands
06/17/2009EP1485381B1 Azolylaminoazine as inhibitors of protein kinases
06/17/2009EP1485375B1 Pyrimidine compounds
06/17/2009EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
06/17/2009EP1390378B1 Pharmaceutically active uridine esters
06/17/2009EP1015496B1 Divalent anti-t cells immunotoxins and use thereof
06/17/2009CN100500210C Use of il-18 inhibitors in hypersensitivity disorders
06/17/2009CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use
06/17/2009CN100500164C Process for preparing bee glue water solution and use
06/17/2009CN100500140C Dermal compositions containing coenzyme Q as active ingredient
06/16/2009US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1172